Menu
Recruiting NCT06505980

Stop, Focus, Plan, and Change: Predicting Parent and Child Responses to a Brief, Telehealth Parent Training

No phase Interventional Behavioral Problem Irritable Mood Parenting Stress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Brief Behavioral Parenting Program.
Who it may be relevant to
Registry conditions: Behavioral Problem, Irritable Mood, Parenting, Stress. Basic parameters: 3 years — 5 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Stop, Focus, Plan, and Change: A Translational Approach to Predict Parent and Child Responses to a Brief, Telehealth Parent Training

Overview

This study will look at who does not improve after doing a behavioral parent training program briefly through telehealth. It will also study ways to make the intervention better for those that do not improve.

Interventions

  • Behavioral Brief Behavioral Parenting Program
    The brief behavioral parenting program is a 6 session, group-based behavioral parent training program. The components include support-building, parenting strategy education, and actively practicing parenting strategies. It is delivered through telehealth.

Primary outcome measures

  • Parenting Scale - Short Form [Time frame: (1) Pre-treatment, (2) Up to 4 weeks after treatment began (Mid-Treatment), and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Caregiver Strain Questionnaire - Short Form [Time frame: (1) Pre-treatment, (2) Up to 4 weeks after treatment began (Mid-Treatment), and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Eyberg Child Behavior Inventory [Time frame: (1) Pre-treatment, (2) Up to 4 weeks after treatment began (Mid-Treatment), and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Sutter Eyberg Student Behavior Inventory [Time frame: (1) Pre-treatment and (3) Up to 12 weeks after treatment began (Post-treatment)]
Secondary outcome measures (7)
  • PROMIS Child Anger / Irritability [Time frame: (1) Pre-treatment, (2) Up to 4 weeks after treatment began (Mid-Treatment), and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Parent-Child Interaction Coding System [Time frame: (1) Pre-treatment and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Dyadic Parent-Child Interaction Coding System [Time frame: (1) Pre-treatment and (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Retrospective Post-Pre Change: Harsh Parenting [Time frame: (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Retrospective Post-Pre Change: Parenting Stress [Time frame: (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Retrospective Post-Pre Change: Child Externalizing Concerns [Time frame: (3) Up to 12 weeks after treatment began (Post-treatment)]
  • Retrospective Post-Pre Change: Child Irritability [Time frame: (3) Up to 12 weeks after treatment began (Post-treatment)]

Eligibility criteria

Inclusion criteria

  • Parent speaks English or Spanish
  • Parent has access to Internet
  • Parent intends to complete treatment
  • Parent reports child has elevated externalizing concerns

Exclusion criteria

  • Child is a ward of the state
  • Child diagnosed with severe medical or nonverbal developmental disability

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Children's Hospital Colorado — Aurora

Identifiers

NCT: NCT06505980 · 21-3184 · 1K23MH134189-01A1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗